Printer Friendly

Effects of aspartame on fetal kidney: a morphometric and stereological study/Efectos del aspartame en el rinon fetal: estudios morfometrico y estereologico.

SUMMARY: The objective of this study was the evaluation of aspartame effects on morphometric alterations of the glomerulus, proximal and distal convoluted tubules and collecting ducts of the rat fetal kidney during organogenesis. Fifteen pregnant rats averaging 24 g body weight, were divided into 3 groups (n=5 each) of controls, rats treated with aspartame exposed to room temperature and rats treated with aspartame heated to 40[degrees]C. Animals were given 14mg / kg aspartame by the intragastric route on the 9th, 10th, and 11th days of pregnancy. Karyometric and stereological techniques estimated morphological changes. A significant decrease of fetal body weight was observed in the group given aspartame kept at room temperature, compared to controls. Karyometry permitted the estimation of the significant nuclear variations observed in the cells of the glomerulus, proximal and distal convoluted tubules and collecting ducts of aspartame-treated rat fetuses. Stereolgical parameters showed statistically significantly increased cell volume and decreased numerical cell density in fetal kidneys of rats treated with aspartame heated to 40[degrees] compared to controls. These results indicate that the use of aspartame leads to alterations in all renal structures studied, suggesting this product's nephrotoxicity.

KEY WORDS: Aspartame; Kidney; Morphometry.

RESUMEN: El objetivo de este estudio fue evaluar las alteraciones morfologicas del aspartame en glomerulos, tubulos contorneados distal y proximal y ductos colectores, en rinones de ratas, durante la organogenesis. Se utilizaron ratas prenadas con un peso promedio de 24g, las que fueron separadas en 3 grupos (n=5 cada uno): un grupo control, otro grupo con ratas tratadas con aspartame y expuestas a temperatura ambiente y un grupo de ratas tratadas con aspartame y mantenidas a 40[degrees] C. A los animales se les administro 14 mg/kg de aspartame via intragastrica en las semanas 9, 10 y 11 de prenez. Con tecnicas cariometricas y estereologicas se estimaron los cambios morfologicos. Una disminucion significativa del peso fetal se observo en el grupo que recibio aspartame y mantenida a temperatura ambiente, comparado con los controles. La cariometria permitio la estimacion de significativas variaciones nucleares observadas en las celulas de los glomerulos, tubulos contorneados distal y proximal y ductos colectores, en los fetos de las ratas tratadas con aspartame. Los parametros estereologicos mostraron un incremento estadisticamente significativo del volumen celular y una disminucion en la densidad de numero de las celulas, en rinones fetales de ratas tratadas con aspartame y mantenidas a 40[degrees] C comparado con los controles. Estos resultados indican que el uso del aspartame lleva consigo alteraciones en todas las estructuras renales estudiadas, lo que sugiere la nefrotoxicidad del producto.

PALABRAS CLAVE: Aspartame; Rinon; Morfometria.

INTRODUCTION

Aspartame is the methylester of N-alpha-aspartyl-Lphenylalanine, a polypeptide widely employed as an artificial, intense synthetic sweetener, having none or insignificant caloric values and a sweeting power higher than that of sucrose. Its use in pharmaceutical products and in nearly 6000 food products, has been approved; among its consumers are those that replace natural foods by "light" ones (AFSSA, 2002).

Aspartame was discovered in 1965; it took 17 years to be approved for consumption by the United States Food and Drug Administration (FDA) in 1981 (Stengik, 1987), and 29 years for its approval by the European Union, in 1994 (ABIAD, 1994). These periods were marked by controversy about its innocuousness that led to requests for toxicological research that still persists at the present time (AIC, 2005).

Several studies on laboratory animals have been made to verify aspartame's toxicity. Recently, a very large experiment confirmed that it is is a multipotential carcinogenic agent when given at a daily dose of 20 mg/kg body weight, an amount well below the acceptable daily dose of 40mg/kg body weight (Sofritti et al., 2004).

Since 1976, several studies have discussed the need of comments on two aspects of aspartame metabolism: production of phenylalanine and relationship to phenylacetonuria, and the appearance of methanol leading to the formation of methanolic acid, and extremely toxic compound to our organism at already relatively low amounts (Liesovouri & Heikki,1991; Davoli,1986; Goerss et al., 2000).

The increased market of dietary products and the development of new synthetic sweetening compounds have not been sufficiently explored. Thus, to verify the risks and benefits of a substance present in our day-by-day use like aspartame, leads us to worry about the actions of its metabolites (aspartic acid, phenylalanine and methanol) to our organism (Boehm & Bada, 1984; Ishi, 1981).

Although renal excretion is the major process for the removal of toxic substances, renal participation in the assimilation of many substances including aspartame, has not been considered.

Bearing in mind their indiscriminate utilization, the understanding of how certain peptides are metabolized by the kidney, may fill in up to now existing gaps in the understanding of their morphometric effects on this organ (Cardello et al., 2001).

The aim of the present study was to evaluate the effect of aspartame on the fetal kidney of rats, by observing through karyometry and stereology, structural changes in the glomerulus, proximal and distal convoluted tubules and collecting duct.

MATERIAL AND METHOD

Fifteen albino female Wistar rats averaging 220-g bodyweight were kept in individual cages and fed a commercial ration and water ad libitum. The study protocol was approved by the Ethics Committee for animal experimentation of the Faculty of Medicine of Sao Jose do Rio Preto, SP, Brazil. Animals were mated overnight with males at the proportion of 1:4; in the morning their vaginal smears were examined for presence of spermatozoids, and if so, were exposed on the 9th, 10th and 11th day of pregnancy i.e., during the period of organogenesis (68), to a 14 mg/kg body weight dose of aspartame.

On the 20th day of pregnancy, the animals were sacrificed, fetuses collected, immediately immersed in Alfac solution, fixed for 5 days, and weighted on a precision balance. To obtain permanent histological preparations, samples from 30% of the treated and control aleatorily chosen offspring, were obtained. Fetal kidneys were dissected and 6 [micro]m slices cut in semi-serial way, and stabilized with hematoxilin-eosin. Morphometry utilized karyometric and stereological evaluations of fetal kidney glomeruli, convoluted proximal and distal tubules and collector ducts.

Glomerular volumes were estimated using an optical Hund 11500 Wetzlar microscope (Helmut Hund Gmbh, Germany), with a 40x objective, and a Leitz Wetzlar camera lucida, yielding a final 490-fold magnification. Glomerule images were projected on white sulfite paper and their contours drawn with a black, No 2 pencil. Twenty structure drawings were obtained from each animal, totalizing 150 for each group.

Karyometry was employed to evaluate nuclear shape and volume as well as their relationships, by averaging the largest and smallest diameters of the epithelial cell nuclei of the proximal and distal convoluted tubules and the renal duct collectors. Slices were analyzed under the above-described microscope with a 100 x objective provided with a Leitz Wetzlar camera lucida, at a final 1240 fold magnification. The contours of the 50 images obtained from each structure were drawn as described above, care being taken to annotate only elliptical images. A millimeter ruler was used to obtain the largest (D) and the smallest (d) axis diameters of the images. These diameters, as well as mean diameters, their ratios, areas, perimeters, volume/area relationships, eccentricity, contour indexes, shape factor and coefficients were evaluated. For stereology, the Merz (Merz, 1968) grid was utilized: slices were focussed under an optical microscope with a 100x objective, and a camera lucida. Images obtained were drawn on the grid. The aim was to obtain cytoplasm volumes, cell volumes, nuclear/cytoplasm relations and numerical density, by counting points remaining superposed to the nuclei and cytoplasm of these cells and on sinusoids of the fetal regions of treated groups, heat-treated groups and controls respectively, totaling the utilization of 20 different fields.

A computer program in Basic Advanced language, developed by Professors Geraldo Maia Campos and Miguel Angel Sala, from the Stomatology Department of the Odontology School of Ribeirao Preto, USP, was utilized. Comparisons between groups were performed by Mood's test for medians, Kruskal-Wallis test, and the Mann-Whitney test, when significant (P<0.05) differences had been found.

RESULTS

Results for initial and final body weight parameters.

Results for the quantitative parameters placenta weight and umbilical--cord length for control rat fetuses and those treated with aspartame are shown in Table II. Glomerulus. It is to be noted that the kidney volume of the kidney of animals given room temperature-treated aspartame and animals given 40[degrees]C-treated, dissolved preparation, were significantly higher than that of the control group (Table III).

Proximal convoluted tubules. Results demonstrated that there was no statistically significant difference between the size of the lesser diameter and the ratio greatest/ smallest diameters, and that there was no modification of the cell shape factor corresponding to the eccentricity, contour index and shape coefficient (Table IV).

Distal convoluted tubules showed increased nuclear diameters, implying an increased perimeter, area and volume of these nuclei in fetuses from both groups of treated rats. The shape of these nuclei (eccentricity, shape coefficient and contour index), presented a significant alterations in animals given room temperature-treated aspartame (Table V).

Collecting ducts revealed significant variations of parameters like the greater diameter, medium diameter, area, perimeter and volume/area ratio in the group given 40[degrees] C-treated, dissolved aspartame. In both treated groups, volumes increased significantly, but there was no significant variation of nuclear shapes compared to controls (Table VI).

Stereology. The data shown on Table VII, present the increase of cell and cytoplasm volumes of aspartame-treated groups. On cell quantification, a significant reduction of the proximal convoluted as well as disappearance of many of these structures at the brush border of 40[degrees]C-treated, diluted aspartame rat fetuses. At the distal convoluted tubules, cell nuclei also were found in lesser numbers.

The glomeruli of the treated groups also showed all their stereological parameters to be altered, with larger, but a reduced number of epithelial cells. Nevertheless, the collection ducts did not present statistical differences regarding their numerical density.

DISCUSSION

The present study showed that daily orogastric administration of 14mg/kg of aspartame on the 9th, 10th and 11th day of pregnancy, led to alterations in the development of renal structures.

Limited studies had been performed and published by others, who administered aspartame from the 7th to the 14th day of pregnancy, an important period for organogenesis in the rat (Sturtevant, 1985; Holder, 1989; Lennon et al., 1980).

In the present experiments, we observed morphological alterations that revealed that aspartame crossed the placenta causing a reduction of fetal weight, following the administration, when kept at room temperature or when diluted and heated to 40[degrees]C. This result agrees with those by others that administered 20mg aspartame /kg body weight daily from the 10th to the 14th day of pregnancy and detected delayed fetal development. Our study suggests that administration of aspartame on the 9th, 10th and 11th day of pregnancy delays fetal growth as expressed by cell damage during this period.

These findings demonstrate the usefulness of the animal model employed for the study of the effects of aspartame on the developing kidney by karyometry and stereology quantification, leading to the finding that there occurs an alteration of kidney structures during pregnancy.

Our observations that aspartame toxicity became more pronounced following its dilution and heating to 40[degrees] C, also agreed with those of Tsang (1985) who also used the experimental model. Their study reports that any form of heating of aspartame, rapidly causes the formation of diketopiperazine (DKP) and free phenylalanine. Significant amounts of DKP are also formed when aspartame is stored in solution at room temperature, but heating considerably hastens this process.

It appears therefore that further work aimed at the elucidation of the mechanisms by which this artificial sweetener determines nuclear and cell alterations in the kidney, is needed.

Based on our results it is to be concluded that karyometry and stereology analyses of groups of fetal rats, suggests nephrotoxicity to the glomerulus, proximal and distal convoluted tubules and to a lesser degree, the collecting ducts, of aspartame kept at room temperature or diluted and heated to 40[degrees] C.

Received: 23-04-2007

Accepted: 07-08-2007

REFERENCES

ABIAD. Associacao Brasileira da Industria de Alimentos Dieteticos. Habitos se atitude do consumidor de produtos dieteticos e de baixo teor de gordura. Sao Paulo, 1994.

AFSSA. Assessment Report: Opinion on a possible link between exposition to aspartame and the incidence of brain tumours in humans 2002. Agence Francaise de Securite Sanitaire des Aliments, Maisons-Alfort. http://www.afssa.fr.

AIC. Aspartame Information Center, 2005. Aspartame Information Center Homepage. Avaliado: http://www.aspartame.org

Boehm, M. F. & Bada, J. L. Racemization of aspartic acid and phenylalanine in the sweetener aspartame at 100[degrees]C. Proc. Natl. Acad. Sci. USA, 81:5263-6, 1984.

Cardello, H. M. A. B.; Silva, M. A. A. P. & Damasio, M. H. Avaliacao tempo-intensidade de docura e amargor do aspartame e ciclamato/ sacarina em equivalencia a sacarose em altas concentracoes. Bol. Centro Pesqui. Process Aliment., 19:391-410, 2001.

Davoli, E. Serum methanol concentrations in rats and in men after a single dose of aspartame. Food and Chemical Toxicology, 24:1879, 1986.

Goerss, A. L.; Wagner, G. C. & Hill, W. L. Acute effects of aspartame on aggression and neurochemistry of rats. Life Sciences, 67:13259, 2000.

Holder, M. D. Effects of perinatal exposure to aspartame on rat pups. Neurotoxicol. Teratol., 11(1):1-6, 1989.

Ishi, H. Incidence of brain tumors in rats fed aspartame. Toxicol. Lett., 7:433-7, 1981.

Lennon, H. D.; Metcalf, L. E.; Mares, S. E.; Smith, J. H.; Nutting, E.F. & Saunders, F. J. The biological properties of aspartame. IV. Effects on reproduction and lactation. Environ. Pathol. Toxicol., 3(5-6):375-86, 1980.

Liesovouri, J. & Heikki, S. Methanol and formic acid toxicity: biochemical mechanisms. Pharmacology & Toxicology, 69: 15763, 1991.

Merz, W. A. Die streekenmessung an gerichteten strukturen im mikroscop und ihre zur bestimmung von oberflachen volumen:relationen im knochengewebe: Mikrosckopie, 22:13242, 1968.

Stengik, L. D. The aspartame history: a model for the clinical testing of a food additive. Am. J. Clin. Nutr., 46(1Suppl):204-15, 1987.

Soffritti, M.; Belpoggi, F.; Padovani, M.; Lauricia, M.; Dagli Spositi, D. & Minardi, F. Life-time carcinogenicity biossay of toluene given by stomach tube to Sprague-Dawley rats. Eur. J. Oncol., 9:91:102, 2004.

Sturtevant, E. Use of aspartame in pregnancy. Int. J. Fertil., 30(1):857, 1985.

Tsang, W. Determination of Aspartame and its breakdown rroducts in soft drinks by reverse-phase chromatography with UV detection. J. Agriculture and Food Chemistry, 33(4):734-8, 1985.

Correspondence to:

Prof. Dr. Reinaldo Azoubel

Faculdade de Medicina de Sao Jose do Rio Preto

Av. Brigadeiro Faria Lima 5416

CEP 15090-000.

Sao Jose do Rio Preto-SP--BRASIL

Email: guilherme@famerp.br

Marielza R. Ismael Martins & Reinaldo Azoubel

Post Graduate Program in Health Sciences--School of Medicine at Sao Jose do Rio Preto, SP, Brazil.

MARTINS, M. R. I. & AZOUBEL, R. Effects of aspartame on fetal kidney: A morphometry and stereological study. Int. J. Morphol., 25(4):689-694, 2007.

MARTINS, M. R. I. & AZOUBEL, R. Efectos del aspartame en el rinon fetal: Estudios morfometrico y estereologico. Int. J. Morphol., 25(4):689694, 2007.
Table I. Average values of initial (I) and final (F) body weights
(g) of controls animals given at the end of pregnancy, room
temperature-treated aspartame, or animals given 40[degrees]C-treated,
dissolved aspartame, respectively.

Parameter            Control

                     Initial             Final

Corporal weight(g)   240.7 [+ or -] 10   346.5 [+ or -] 13

                     Room temperature-treated
                     aspartame

                     Initial             Final

Corporal weight(g)   245.1 [+ or -] 8    320.1 [+ or -] 6 *

                     40[degrees]C-treated, dissolved
                     aspartame

                     Initial             Final

Corporal weight(g)   242.8 [+ or -] 10   331.9 * [+ or -] 11

* p = 0.004 vs. control.

Table II. Average values of placenta weight (g) and umbilical cord
length (cm) of control rats fetuses and treated with aspartame.

                                          Room temperature
Parameter                   Control       treated aspartame

Placenta weight         0.46 [+ or -] 7   0.25 [+ or -] 10 *
Umbilical cord length   1.86 [+ or -] 6   1.81 [+ or -] 8

                        40[degrees]C-treated,
Parameter               dissolved aspartame     P

Placenta weight         0.26 [+ or -] 5         0.004 *
Umbilical cord length   1.82 [+ or -] 10        0.075

* p < 0.05 vs. control.

Table III. Median values of nuclear volumes of the glomerulus, in
[micro][m.sup.3], of fetuses from control rats, animals given room
temperature-treated aspartame and animals given 40[degrees]C-treated,
dissolved aspartame, respectively.

                    Room temperature-   40[degrees]C-treated,
Fetuses   Control   treated aspartame    diluted aspartame

1          1599           2102                  1784
2           648           2652                  1831
3          1347           1637                  2254
4          1396           1793                  1994
5          1422           2109                  2171
Mediana    1396           2102 *                1994 *
dIQ         513            665                   405

* p < 0.05 vs. control; dIQ -interquartilica diference.

Table IV. Median values of nuclear parameters (n=50) of cells of the
proximal convoluted tubules of the fetuses from controls, animals
given room temperature-treated aspartame and animals given
40[degrees]C-treated, dissolved aspartame, respectively.

                                                  Room temperature-
Nuclear parameter                Control          treated aspartame

Shortest axis               7.66 [+ or -] 1.94    8.22 [+ or -] 0.14
Geometric mean axis         8.36 [+ or -] 1.82    9.06 [+ or -] 0.42
Ratio D/d                   1.22 [+ or -] 0.37    1.15 [+ or -] 0.14
Volume ([micro][m.sup.3])    341 [+ or -] 182      428 [+ or -] 212
Area ([micro][m.sup.2])     56.9 [+ or -] 22.3    66.6 [+ or -] 10.9 *
Perimeter ([micro]m)         265 [+ or -] 5.3     28.6 [+ or -] 2.6 *
Ratio V/A                   5.58 [+ or -] 1.21    6.04 [+ or -] 0.28 *
Eccentricity                0.52 [+ or -] 0.16    0.45 [+ or -] 0.07
Shape factor                0.98 [+ or -] 0.01    0.99 [+ or -] 0.01
Countor index               3.58 [+ or -] 0.06    3.56 [+ or -] 0.04

                            40[degrees]C-treated,
Nuclear parameter            diluted aspartame      P

Shortest axis                8.44 [+ or -] 1,71     0.082
Geometric mean axis         10.75 [+ or -] 1,42 *   0.006 *
Ratio D/d                    1.22 [+ or -] 0,37     0.343
Volume ([micro][m.sup.3])     685 [+ or -] 122 *    0.006 *
Area ([micro][m.sup.2])      68.0 [+ or -] 16,8 *   0.031 *
Perimeter ([micro]m)         30.5 [+ or -] 14,3 *   0.006 *
Ratio V/A                    6.54 [+ or -] 1,55 *   0.031 *
Eccentricity                 0.54 [+ or -] 0,14     0.435
Shape factor                 0.86 [+ or -] 0,20     0.153
Countor index                3.45 [+ or -] 1,05     0.153

Mediana [+ or -] interquartilica diference; * p < 0.05 vs. control.

Table V. Median values of nuclear parameters (n=50) of cells
of the distal convoluted tubules of the fetuses from controls,
animals given room temperature-treated aspartame and animals
Oven 40[degrees]C-treated, dissolved aspartame, respectively.

                                                   Room temperature-
Nuclear parameter                Control          treated aspartame

Longest axis                7.15 [+ or -] 0.88   10.80 [+ or -] 1.55 *
Shortest axis               5.34 [+ or -] 0.65    8.42 [+ or -] 1.29 *
Geometric mean axis         6.15 [+ or -] 0.70    9.82 [+ or -] 1.74 *
Ratio D/d                   1.40 [+ or -] 0.11    1.67 [+ or -] 0.20 *
Volume ([micro][m.sup.3])    128 [+ or -] 22       413 [+ or -] 106 *
Area ([micro][m.sup.2])     30.2 [+ or -] 6.3     70.6 [+ or -] 3.8 *
Perimeter ([micro]m)        19.8 [+ or -] 2.3     30.5 [+ or -] 3.3 *
Ratio V/A                   4.10 [+ or -] 0.47    6.14 [+ or -] 0.57 *
Eccentricity                0.64 [+ or -] 0.05    0.74 [+ or -] 0.15 *
Shape factor                0.95 [+ or -] 0.02    0.82 [+ or -] 0.13 *
Countor index               3.63 [+ or -] 0.04    3.72 [+ or -] 0.07 *

                            40[degrees]C-treated,
Nuclear parameter           dissolved aspartame     P

Longest axis                12.98 [+ or -] 1.33 *   0.006 *
Shortest axis                8.92 [+ or -] 4.12 *   0.031 *
Geometric mean axis         10.85 [+ or -] 1.50 *   0.006 *
Ratio D/d                    1.58 [+ or -] 0.17 *   0.031 *
Volume ([micro][m.sup.3])     633 [+ or -] 189 *    0.006 *
Area ([micro][m.sup.2])      64.2 [+ or -] 6.1 *    0.006 *
Perimeter ([micro]m)         30.7 [+ or -] 7.0 *    0.031 *
Ratio V/A                    6.94 [+ or -] 2.08 *   0.031 *
Eccentricity                  055 [+ or -] 0.15     0.003 *
Shape factor                 0.86 [+ or -] 0.11     0.003 *
Countor index                3.68 [+ or -] 0.56     0.031 *

Mediana [+ or -] interquartilica diference; * p < 0.05 vs. control.

Table VI. Median values of nuclear parameters (n=50) of cells of the
collecting ducts of the fetuses from controls, animals given room
temperature-treated aspartame and animals given 40[degrees]C-treated,
dissolved aspartame, respectively.

                                                 Room temperature-
Nuclear parameter           Control              treated aspartame

Longest axis                7.84 [+ or -] 1.57   8.45 [+ or -] 0.51
Shortest axis               5.94 [+ or -] 1.26   7.42 [+ or -] 0.51
Geometric mean axis         6.44 [+ or -] 1.44   7.59 [+ or -] 0.67
Ratio D/d                   1.45 [+ or -] 0,29   1,30 [+ or -] 0,13
Volume ([micro][m.sup.3])    151 [+ or -] 115     332 [+ or -] 63 *
Area ([micro][m.sup.2])     33.5 [+ or -] 15.8   43.5 [+ or -] 10.3
Perimeter ([micro]m)          21 [+ or -] 4.3    25.7 [+ or -] 5.3
Ratio V/A                   4.29 [+ or -] 0.96   5.39 [+ or -] 0.70
Eccentricity                0.62 [+ or -] 0.21   0.55 [+ or -] 0.07
Shape factor                0.94 [+ or -] 0.05   0.97 [+ or -] 0.04
Countor index               3.66 [+ or -] 0.11   3.61 [+ or -] 0.14

                            40[degrees]C-treated,
Nuclear parameter           diluted aspartame       P

Longest axis                10.89 [+ or -] 2.14 *   0.006 *
Shortest axis                7.97 [+ or -] 0.36     0.060
Geometric mean axis          9.53 [+ or -] 1.37 *   0.006 *
Ratio D/d                    1,55 [+ or -] 0,29     0.343
Volume ([micro][m.sup.3])     489 [+ or -] 168 *    0.006 *
Area ([micro][m.sup.2])      73.0 [+ or -] 13.5 *   0.006 *
Perimeter ([micro]m)         34.1 [+ or -] 5.2 *    0,006 *
Ratio V/A                    7.15 [+ or -] 0.60 *   0.006 *
Eccentricity                 0.47 [+ or -] 0.44     0.153
Shape factor                 0.93 [+ or -] 0.06     0.453
Countor index                3.68 [+ or -] 0.34     0.765

Mediana [+ or -] interquartilica diference; * p < 0.05 vs. control.

Table VII. Overall picture of the medians of stereological parameters
of glomerulus, proximal convoluted tubule, distal convoluted tubule
and collection duct of rat fetuses of controls, of animals given
room temperature-treated aspartame and of animals given
40[degrees]C-treated, dissolved aspartame, respectively.

                                             Room temperature
Stereological parameter            Control   treated aspartame

Cell volume      Glomerulus        5369.3        5924.3 *
                 P. C. tubule      2118.7        2564.3
                 D. C. tubule      1965.3        2489.2 *
                 Collection duct   1756.3        1935.5 *
Cytoplasm        Glomerulus        6505.7        6607.8 *
volume           P. C. tubule      3897.3          4122
                 D. C. tubule      2565.3        2935.6 *
                 Collection duct   1854.3        2165.4 *
Ratio nuclei/    Glomerulus        0.5437        0.5568 *
cytoplasm.       P. C. tubule      0.1574        0.1823
                 D. C.tubule       0.1355        0.1412 *
                 Collection duct   0.1023        0.1255 *
Cell numerical   Glomerulus        245425        150588 *
density          P. C. tubule      150588        165598
                 D. C. tubule      132564        125658 *
                 Collection duct   112367        125438

                                    40[degrees]C-
                                   treated, diluted
Stereological parameter               aspartame       P

Cell volume      Glomerulus            6156.7 *       0.007 *
                 P. C. tubule          2956.4 *       0.006 *
                 D. C. tubule          2372.0 *       0.026 *
                 Collection duct       2235.4 *       0.006 *
Cytoplasm        Glomerulus            6955.0 *       0.007 *
volume           P. C. tubule          4625.3 *       0.006 *
                 D. C. tubule          3024.2 *       0.030 *
                 Collection duct       2563.2 *       0.007 *
Ratio nuclei/    Glomerulus            0.7533 *       0.007 *
cytoplasm.       P. C. tubule           0.196         0.69
                 D. C.tubule           0.1563 *       0.006 *
                 Collection duct       0.1333 *       0.007 *
Cell numerical   Glomerulus            148967 *       0.007 *
density          P. C. tubule          130566 *       0.007 *
                 D. C. tubule          112500 *       0.026 *
                 Collection duct       1095433        0.082

Mediana [+ or -] interquartilica diference; * p < 0.05 vs. control.
COPYRIGHT 2007 Universidad de La Frontera, Facultad de Medicina
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Martins, Marielza R. Ismael; Azoubel, Reinaldo
Publication:International Journal of Morphology
Date:Dec 1, 2007
Words:3914
Previous Article:Anatomical behavior of the celiacomesenteric artery of pirarucu Arapaima gigas Cuvier, 1817 (Osteoglossiforme, Arapaimidae)/Comportamiento anatomico...
Next Article:Microwave fixation in rat fetuses tissues: histological and immunohistochemical analysis/Fijacion de tejidos de fetos de ratas por microondas:...

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters